TRAQinform Assessment of Immunotherapy Response
Recruiting
The intent of this study is to evaluate the actionable information output from the TRAQinform Immuno technology in a prospective, non-interventional clinical study. Subjects with metastatic melanoma treated with standard of care (SOC) dual-agent immunotherapy will be enrolled. Subjects will receive SOC immunotherapy monitored for treatment response with FDG PET/CT's at baseline (SOC), after 3-4 weeks of treatment (non-SOC) and 12 at weeks of treatment (SOC).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2024
Locations: Massachusetts General Hospital, Boston, Massachusetts +1 locations
Conditions: Melanoma
Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women
Recruiting
The purpose of this study is to assess how time restricted eating interventions impact eating behaviors, diet quality, and body composition in women ages 20-29 years. Participants will be asked to limit all food and drinks (except water and some non-caloric beverages) to a 10-hour period during the day for four weeks. Participants will follow their usual eating and activity patterns for one week before starting, and follow whatever eating pattern they want for 4 weeks after finishing.
Gender:
ALL
Ages:
Between 20 years and 29 years
Trial Updated:
07/29/2024
Locations: University of Delaware, Newark, Delaware
Conditions: Time Restricted Eating, Eating Behavior, Diet, Healthy, Nutrition, Healthy
Real-life Dual-Task Training
Recruiting
Older adults have difficulty optimizing two tasks at once and typically experience greater interference than younger adults when dual-tasking, meaningful that there is greater decline in performance of at least one task when comparing single and dual-tasking. Difficulty dual-tasking may actually predict falls in community-dwelling older adults. Dual-task training has been shown to improve cognitive outcomes (attention, memory), motor outcomes (balance, gait), and dual-task performance in older a... Read More
Gender:
ALL
Ages:
65 years and above
Trial Updated:
07/29/2024
Locations: Colorado State University, Fort Collins, Colorado
Conditions: Fall
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
Recruiting
This is a single center, prospective cross-sectional study of women who have completed therapy for primary breast cancer within 5 years of diagnosis and are at increased risk for relapse. Patients will undergo screening bone marrow aspirate to test for presence of disseminated tumor cells (DTCs) Patients who harbor DTCs will be offered the opportunity for enrollment into a clinical trial of therapy targeting DTCs to prevent recurrence (separate protocols).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2024
Locations: Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
Conditions: Breast Cancer
Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
Recruiting
The investigators are investigating whether home-based tDCS over the course of four weeks can improve ADHD symptom severity and improve dysexecutive functioning (cognitive control). Further, the investigators are investigating whether there is a dose-dependent response to tDCS.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
07/29/2024
Locations: Massachusetts General Hospital, Charlestown, Massachusetts
Conditions: Attention Deficit Disorder, Attention Deficit Disorder With Hyperactivity
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
Recruiting
Girls and women 12-35 years old with obesity and polycystic ovarian syndrome who are on or off metformin, will receive a glucagon like peptide-1 receptor agonist intervention for 10 months to induce metabolic changes, weight loss and improve reproductive abnormalities.
Gender:
FEMALE
Ages:
Between 12 years and 35 years
Trial Updated:
07/29/2024
Locations: University of Colorado Anschutz/Children's Hospital Colorado Aurora, Aurora, Colorado
Conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Recruiting
This study is for people who have multiple sclerosis, acute leukemia (in remission), or long-COVID and a Body Mass Index over 27 and may struggle with cognitive issues such as remembering information, concentrating, or making decisions that affect everyday life. By doing this study, researchers hope to learn how liraglutide (Saxenda®), a weight loss drug, affects levels of a certain disease marker in the body called Brain Derived Neurotrophic Factor (BDNF). Participation in this research will l... Read More
Gender:
ALL
Ages:
Between 18 years and 40 years
Trial Updated:
07/29/2024
Locations: University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois
Conditions: Multiple Sclerosis, Long COVID, Long Covid19, Obese, Obesity, Obesity, Morbid, Acute Leukemia in Remission
Brain Vascular and Neurocognitive Health
Recruiting
The overall research objective of this proposal is to determine the acute and chronic impact of transcranial photobiomodulation on indices of cerebral vascular health and neurocognitive function.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
07/29/2024
Locations: UT Arlington - Science and Engineering Innovation and Research Building, Arlington, Texas
Conditions: Cognitive Decline, Cognitive Dysfunction, Alzheimer Disease, Vascular Disease, Peripheral
A Crowd Sourcing Platform for Patients With Cancer
Recruiting
All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2024
Locations: All4Cure, Seattle, Washington
Conditions: Cancer
Adjunctive Bright Light Therapy for Opioid Use Disorder
Recruiting
Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use disorder.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
07/29/2024
Locations: Arizona State University, Phoenix, Arizona
Conditions: Opioid Use Disorder, Sleep Disturbance
Testing the Effects of RISE on Eating Pathology
Recruiting
Interoception is the process of perceiving one's bodily sensations. Interoception is critical for survival and maintaining homeostasis, as it motivates sensation- and need-specific autonomic reflexes and adaptive behaviors (e.g., eating when hungry, terminating eating upon fullness, drinking when thirsty). Not all individuals have accurate interoceptive abilities. Individuals with eating disorders often have low perception of gastrointestinal, pain, and emotion sensations. Interoceptive dysfunct... Read More
Gender:
ALL
Ages:
Between 10 years and 65 years
Trial Updated:
07/29/2024
Locations: Louisville Center For Eating Disorders, Louisville, Kentucky
Conditions: Eating Disorder Symptoms
A Study of Oral Kavalactones Effect on Nurses
Recruiting
This research study is being done to assess the impact of taking Kava extract (Piper methysticum), a dietary supplement on cortisol in a healthy nursing population.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2024
Locations: Mayo Clinic Minnesota, Rochester, Minnesota
Conditions: Stress